Mark Chapman

Long only, contrarian, event-driven
Mark Chapman
Long only, contrarian, event-driven
Contributor since: 2013
9/15/15
Mark Chapman
$AERI:suspect Rocket 2 read will be after close today or tmrw. Expect to meet primary endpoint, although the key takeaway is actual data.
Sold most of my holding AH at $30, results do not appear that great, but maybe CC will convince me otherwise.
6/12/15
Mark Chapman
$ESPR: suspect this continues to drift lower. May consider position near $50.
I go by my own research, not other analysts. See my articles on ESPR.
6/12/15
see my mail to you
2/25/15
Mark Chapman
$ATRS: terrific results from topline QS-T pk data. Working some valuation/partnering scenarios.
2/17/15
Mark Chapman
$atrs: Oral arguments in medac case scheduled for March 6 have been adjourned indefinitely.
2/18/15
Mark, do you know why the talks were adjourned?
There are several reasons, but mainly because Medac's patent is being reviewed by the PTAB.If patent is invalidated, then Medac has no case
12/8/14
Mark Chapman
Generic EpiPen Could Give These 2 Stocks A Jolt Of Adrenaline $TEVA, $ATRS http://seekingalpha.com/a/1mqbp
11/25/14
Mark Chapman
Update: Nuance Q4 And FY 2014 Earnings $NUAN http://seekingalpha.com/a/1m1zb
11/13/14
Mark Chapman
Update: Banco Macro's Q3 2014 Earnings $BMA http://seekingalpha.com/a/1ldd7
11/11/14
Mark Chapman
Analyzing Antares Pharma 3Q2014 Earnings $ATRS http://seekingalpha.com/a/1l7vz
10/30/14
Mark Chapman
Nuance Investors: Quit Fretting About Apple, Inflection Point Is Coming $NUAN http://seekingalpha.com/a/1k4eb
10/22/14
Mark Chapman
$EXXI, $FCX: Per $CLB press release, ultra deep well was succesfully completed and ready to complete another ultra deep well. Great news.
10/12/14
Mark Chapman
Update: Antares Pharma Looks To Improve Intellectual Property $ATRS http://seekingalpha.com/a/1is99
9/26/14
Mark Chapman
Which Oil Service Company Is The Cheapest? http://seekingalpha.com/a/1i3zd
9/24/14
Mark Chapman
$ATRS: Short interest back up to 16.7m shares, representing 21 days to cover... looking to add on additional weakness next few weeks.
9/12/14
Mark Chapman
Antares Pharma: Significant Value Or Value Trap? $ATRS http://seekingalpha.com/a/1hdhh
8/12/14
Mark Chapman
Finally some insider buying at $ATRS
There actually appears to be a lot going on behind the scenes. Hope to publish update in next few weeks.
8/14/14
Funny that it would close with an almost 7% gain the day after you mention there's a lot going on behind the scenes.
7/30/14
Mark Chapman
$atrs: With $teva reporting tomorrow, I just added to Antares position. You never know...
$atrs.......mark, you sounded like you did "know" back in March when you said 'capitulation' etc. but collapse was just getting started.
Yes, this drop has obviously been much steeper than I thought. I've been dollar cost averaging down, since I still like the fundmentals. GL
5/20/14
Mark Chapman
Is Antares Pharma A Short-Squeeze Candidate? $ATRS http://seekingalpha.com/a/1broz
5/9/14
Mark Chapman
$ATRS: sure hope for good CC or lookout below today.
Great CC for once, thanks SA for getting transcript up fast. A little disappointed for not revealing $TEVA pens, but coming. Article coming
5/9/14
Looking forward to your piece Mark. ATRS is undervalued and undercovered.
5/5/14
Mark Chapman
$ATRS: looking for big gains this week.
Very Disappointed up to this point...Here`'s hoping
Everything seems to be falling in place to finally provide update on Teva pens, combined with huge short interest,this could get interesting
3/26/14
Mark Chapman
Antares Pharma: Recent Sell-Off Provides Great Entry Point $ATRS http://seekingalpha.com/a/1967z
3/24/14
Mark Chapman
$ATRS: I think we are seeing capitulation today.
3/20/14
Mark Chapman
$LGF seesaw action. As long term holder, I am actually glad to seelowered Divergent expectations. I am looking for $85m opening weekend.
3/13/14
Mark Chapman
$CMO: unexpected dividend increase bodes well for stock moving forward.
3/12/14
Mark Chapman
$pfe halted news pending. $ATRS results tomorrow morning...
3/13/14
Another buying opportunity. LONG ATRS
Agree. Have a feeling the stock will pop once the 10k is filed.
3/11/14
Mark Chapman
$ATRS: selloff because of Medac countersuit is amusing. It only validates the market potential for otrexup, right?
2/25/14
Mark Chapman
$ATRS likely falling due to Dr. Reddy $RDY launch of sumatriptan autoinjector.
2/25/14
so that explains today's 0.4% dip
2/25/14
Mark Chapman
Could Brinker's Use Of Technology Revolutionize The Restaurant Industry? $EAT http://seekingalpha.com/a/17s9d
2/24/14
Mark Chapman
Congrats to all who held $ERN through dividend.
2/21/14
Mark Chapman
Would think that $ERN share price would adjust for share split before open on Monday.
5/19/15
congrats mark, weve been long cak for some time, nevr sold, more great news coming, earnings will explode in 2016
2/11/14
Mark Chapman
Gotta think there are issues looming at $nuan when capital allocation isn't discussed on cc.
1/30/14
Mark Chapman
$CLB: great buying opportunity on the drop today.
1/29/14
Mark Chapman
Could Teva & Pfizer End Up In A Bidding War For Antares? $ATRS http://seekingalpha.com/a/16agd